Influence of Hyperbilirubinaemia on Two Different Near Infrared Spectroscopy Devices
NIRS_GREFFE
1 other identifier
interventional
33
1 country
1
Brief Summary
Protocol Near infrared spectroscopy liver transplants: comparison of two monitoring of Near infrared spectroscopy in pediatric liver transplant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2019
CompletedStudy Start
First participant enrolled
March 15, 2019
CompletedFirst Posted
Study publicly available on registry
May 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2020
CompletedMarch 18, 2021
March 1, 2021
1.6 years
March 4, 2019
March 17, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
influence of chromophores such as bilirubin on oximetry values provided by two different devices
measure of oximetry values by two different devices at different time points in function of serum bilirubin levels
From Day 0 of surgery until arrival at pediatric intensive care unit (up to 12 hours)
Study Arms (1)
Pediatric liver transplant patients
OTHERUsing somatic and cerebral Near infrared spectroscopy devices
Interventions
somatic and cerebral oximetry by INVOS in pediatric liver transplantation
somatic and cerebral oximetry with Foresight device in pediatric liver transplantation
Eligibility Criteria
You may qualify if:
- Pediatric patients 0 to 18 years, with a liver transplant with living donor program of our institution
- Free, informed and written consent signed by the investigator or employees and by the legal guardians of minor patients in the days preceding the procedure
You may not qualify if:
- refusal of the patient or his parents to consent
- known brain or Neurological pathology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cliniques Universitaires Saint-Luc
Brussels, 1200, Belgium
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Natalia MAGASICH-AIROLA, MD
natalia.magasich@uclouvain.be
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2019
First Posted
May 10, 2019
Study Start
March 15, 2019
Primary Completion
October 15, 2020
Study Completion
October 15, 2020
Last Updated
March 18, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share